Beauty & Cosmetics Pharmaceutical
Keywords
healthcare biotechnology life sciences orphan medicines rheumatology primary care patient advocacy
Horizon Therapeutics plc (Nasdaq: HZNP) is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.[3] Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales.[4] In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system.[5][6] On May 2, 2019 shareholders of the company approved the change of the company's name to Horizon Therapeutics plc.[7]

read more
Horizon Therapeutics plc (Nasdaq: HZNP) is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.[3] Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales.[4] In 2014 Horizon executed a tax inversion to move its legal headquarters to Ireland to avail of Ireland's low tax rates and beneficial corporate tax system.[5][6] On May 2, 2019 shareholders of the company approved the change of the company's name to Horizon Therapeutics plc.[7]

read more

Sponsor Details

People
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about Horizon Therapeutics and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Horizon Therapeutics, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.